A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Published: April 19, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Australia Patent: NOVARTIS Files Application for 'Antibody drug conjugates and methods for making thereof'
Published: April 19, 2024 by Australian Government
Australia: Regeneron Pharmaceuticals Receives Patent for 'Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist'
Published: April 19, 2024 by Australian Government
Australia Patent: BIOGEN MA Files Application for 'PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS'
Published: April 19, 2024 by Australian Government
Biopharma firm CureVac NV and the University of Texas MD Anderson Cancer Center partner to develop novel mRNA-based cancer vaccines; the collaboration will focus on creating vaccines for hematological and solid tumor indications
Published: April 18, 2024 by Marketline - Deals

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count